This site is intended for healthcare professionals only
LoginRegister
Fludrocortisone 0.2 mg Study Rejected by CDSCO Panel Over Potential Adverse EffectsFludrocortisone 0.2 mg Study Rejected by CDSCO Panel Over Potential Adverse Effects
Chemists Launch Indefinite Strike Over Coldrif Tragedy, Demand Action Against Manufacturers Not SellersChemists Launch Indefinite Strike Over Coldrif Tragedy, Demand Action Against Manufacturers Not...
Unequal Trials in New Drug Approvals: CDSCO Seeks Feedback for Policy ReformUnequal Trials in New Drug Approvals: CDSCO Seeks Feedback for Policy Reform
Inside Coldrif Scandal: Tamil Nadu Plant Used Paint-Grade Chemicals, Violated 300+ Drug NormsInside Coldrif Scandal: Tamil Nadu Plant Used Paint-Grade Chemicals, Violated 300+ Drug Norms
3 cough syrups recalled, none exported: CDSCO responds to WHO3 cough syrups recalled, none exported: CDSCO responds to WHO
SC to hear plea seeking CBI probe into cough syrup deaths on October 10SC to hear plea seeking CBI probe into cough syrup deaths on October 10
Cough syrup crisis: Tamil Nadu suspends 2 drug inspectors, moves to close pharma coCough syrup crisis: Tamil Nadu suspends 2 drug inspectors, moves to close pharma co
TN based cough syrup pharma owner arrested in ChennaiTN based cough syrup pharma owner arrested in Chennai
Stop using these cough syrups immediately, warns Telangana Drug AuthorityStop using these cough syrups immediately, warns Telangana Drug Authority
Lupin plans to build new pharma manufacturing plant in Coral SpringsLupin plans to build new pharma manufacturing plant in Coral Springs
Abbott India appoints Tushar Singh as Plant Director - GoaAbbott India appoints Tushar Singh as Plant Director - Goa
After Cough Syrup Deaths, CDSCO Tightens Oversight on Drug Testing ComplianceAfter Cough Syrup Deaths, CDSCO Tightens Oversight on Drug Testing Compliance
X